SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Catalytica Energy Systems, Inc. (CESI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: smh who wrote (1420)12/4/1999 7:20:00 PM
From: Erik T  Read Replies (1) of 1514
 
My biggest disappointment to date is that Enron, which has the vision, incentive, and means, has apparently done little to make it happen.

That I agree with, whole-heartedly. It will be hard for me to accept that Xonon will not be a huge success. That technology was the basis for my investment in Catalytica. I suppose the price decline could very easily represent "rapidly deteriorating confidence in the future of Xonon." The company really has done a poor job getting orders, considering the technology has been ready for a couple years, and the first memorandum of understanding with GE was signed over two years ago. I suspect management still figures there is significant value there, otherwise they could easily sell-off CCSI to someone like GE for a measly couple hundred million (wouldn't even show up on GE's balance sheet). Unfortunately, I doubt CTAL will split up the two divisions, as pharm supplies the revenue for CCSI to continue. I guess I must just sit back and trust management, which I do.

Erik
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext